Walvax Biotechnology Hits Day Low of CNY 11.15 Amid Price Pressure

Walvax Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 5.07% on June 8, 2026. The stock reached an intraday low of CNY 11.15, reflecting a challenging trading environment. Over the past week, Walvax has seen a decrease of 10.59%, significantly underperforming compared to the China Shanghai Composite, which fell by 2.43% during the same period. In terms of longer-term performance, Walvax's stock has declined by 15.88% over the past month and a substantial 57.65% over the last three years. Despite a positive net profit growth of 4082.41% reported in March, the company has faced difficulties, with operating profit showing a significant negative trend over the last five years. The current market capitalization stands at CNY 17,496 million, and the stock carries a P/E ratio of 69.00. While the company has declared positive results for the last two consecutive quarters, its return on equity remains low at 3.40%, indicating a cautious outlook for investors. The stock's high dividend yield of 0.28% may provide some appeal, but the overall performance metrics suggest a complex financial landscape for Walvax Biotechnology.